Please try another search
Shandong Sito Bio-technology Co., Ltd. researches and develops new steroid biomedicine intermediates. Its products include 9a-hydroxyandrostenedione, 17a-hydroxyprogesterone, 17a-hydroxy progesterone derivatives, anecort acetate, neomycin sulfate, progesterone intermediate, tetraene, androstenedione, ketal, 3-ketal, norandrostenedione, and betamethasone epoxy hydrolyzate, as well as 1,4-androstenedione. The company was founded in 2002 and is based in Heze, China.
Name | Age | Since | Title |
---|---|---|---|
Qi Ming Zhang | 62 | - | Independent Director |
Bei Jun Qing | 42 | - | Independent Director |
Ya Ping Ma | 50 | - | Director |
Peng Fei Tu | 60 | - | Independent Director |
Qi Mi | 33 | - | Chairman |
Chao Chao Liu | 38 | - | Supervisor |
Wen Xia Zhang | 38 | - | Chairman of the Supervisory Board |
Chang Jiu Xu | 35 | - | Supervisor |
Xu Sheng Kong | 62 | - | Director |
Lu Li | 46 | 2019 | Deputy GM, Board Secretary & Director |
Li Kang | - | 2023 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review